galantamin teva 4 mg tabletti, kalvopäällysteinen
teva sweden ab - galantamini hydrobromidum - tabletti, kalvopäällysteinen - 4 mg - galantamiini
galantamin teva 8 mg tabletti, kalvopäällysteinen
teva sweden ab - galantamini hydrobromidum - tabletti, kalvopäällysteinen - 8 mg - galantamiini
galantamin teva 12 mg tabletti, kalvopäällysteinen
teva sweden ab - galantamini hydrobromidum - tabletti, kalvopäällysteinen - 12 mg - galantamiini
galantamin sandoz 4 mg tabletti, kalvopäällysteinen
sandoz a/s - galantamini hydrobromidum - tabletti, kalvopäällysteinen - 4 mg - galantamiini
galantamin sandoz 8 mg tabletti, kalvopäällysteinen
sandoz a/s - galantamini hydrobromidum - tabletti, kalvopäällysteinen - 8 mg - galantamiini
galantamin sandoz 12 mg tabletti, kalvopäällysteinen
sandoz a/s - galantamini hydrobromidum - tabletti, kalvopäällysteinen - 12 mg - galantamiini
galantamin hexal 4 mg tabletti, kalvopäällysteinen
hexal a/s - galantamini hydrobromidum - tabletti, kalvopäällysteinen - 4 mg - galantamiini
galantamin hexal 8 mg tabletti, kalvopäällysteinen
hexal a/s - galantamini hydrobromidum - tabletti, kalvopäällysteinen - 8 mg - galantamiini
galantamin hexal 12 mg tabletti, kalvopäällysteinen
hexal a/s - galantamini hydrobromidum - tabletti, kalvopäällysteinen - 12 mg - galantamiini
sitagliptin / metformin hydrochloride sun
sun pharmaceutical industries europe b.v. - sitagliptin fumarate, metformin hydrochloride - diabetes mellitus, tyyppi 2 - diabeetilla käytettävät lääkkeet - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride sun is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride sun is indicated in combination with a sulphonylurea (i. kolmen lääkkeen yhdistelmähoito) lisänä ruokavalion ja liikunnan ohella potilaille riittävästi hallinnassa heidän maksimaalinen siedetty annos metformiinia ja sulfonyyliureaa. sitagliptin/metformin hydrochloride sun is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. sitagliptin/metformin hydrochloride sun is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.